Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

B. London, Wendy; P Castleberry, R; K. Matthay, Katherine; Thomas Look, A.; C. Seeger, Robert; Shimada, Hiroyuki; S. Thorner, Paul; M Brodeur, G; M. Maris, John; Patrick Reynolds, C.; L. Cohn, Susan

doi:10.1200/jco.2005.05.571

Public

Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

Published in Journal of Clinical Oncology • Aug 23, 2005

Authors:

Wendy B. London

R P Castleberry

Katherine K. Matthay

Abstract

PURPOSE: In the Children's Oncology Group, risk group assignment for neuroblastoma is critical for therapeutic decisions, and patients are stratified by International Neuroblastoma Staging System stage, MYCN status, ploidy, Shimada histopathology, and diagnosis age. Age less than 365 days has been a...

Subject

Medicine

Cutoff

Neuroblastoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!